Lithium trihydroxy(2-methylpyridin-4-yl)borate

Catalog No.: 
ACWTUA619
CAS No.: 
1451391-59-5
Molecular Formula: 
C6H9BLiNO3
Molecular Weight: 
160.90
Lithium trihydroxy(2-methylpyridin-4-yl)borate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$253.00InquiryInquiry
1g95%$627.00InquiryInquiry
5g95%$758.00InquiryInquiry
25g95%$1456.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameLithium trihydroxy(2-methylpyridin-4-yl)borate
IUPAC Namelithium trihydroxy(2-methylpyridin-4-yl)borate
MDL No.MFCD23704688
Molecular FormulaC6H9BLiNO3
Molecular Weight160.90
SMILESCC1=NC=CC([B-](O)(O)O)=C1.[Li+]
InChI KeyBIAQKNKLRDITDC-UHFFFAOYSA-N
SynonymlithiuM trihydroxy(2-Methylpyridin-4-yl)borate
CAS No.1451391-59-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWTUA619 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBGYS451 route compound structure diagram
    ACBGYS45122282-99-1In Stock
  2. Plus
  3. ACLUJV235 route compound structure diagram
    ACLUJV23513675-18-8In Stock
  4. Then
  5. ACWTUA619 route product structure diagram
    ACWTUA6191451391-59-5
Inquiry

2. ACWTUA619 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBGYS451 route compound structure diagram
    ACBGYS45122282-99-1In Stock
  2. Plus
  3. ACUCSB359 route compound structure diagram
    ACUCSB35913703-82-7In Stock
  4. Then
  5. ACWTUA619 route product structure diagram
    ACWTUA6191451391-59-5
Inquiry

3. ACWTUA619 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWTUA619 route product structure diagram
    ACWTUA6191451391-59-5
Inquiry

Comments (0)